Simpson N H, Milner A E, Al-Rubeai M
Centre for Biochemical Engineering, School of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom.
Biotechnol Bioeng. 1997 Apr 5;54(1):1-16. doi: 10.1002/(SICI)1097-0290(19970405)54:1<1::AID-BIT1>3.0.CO;2-K.
TB/C3 hybridoma cells were transected with either pEF-MClneopA or pEF bcl2-MClneopA vectors to produce a control cell line (TB/C3 pEF) and a cell line that overexpresses the "antiapoptotic" human bcl-2 protein (TB/C3 bcl2). Flow cytometry analysis of intracellular bcl-2 protein levels enabled near on-line monitoring of the stability of bcl-2 expression in the absence of drug selection. It was possible to maintain spontaneous selection of cells with the overexpression of bcl-2 protein during semicontinuous cultures at very low dilution rates, where cells were subjected to the selective conditions of nutrient limitation and high toxic metabolite concentrations. Interestingly, cells that overexpressed bcl-2 were adapted to suspension culture conditions significantly faster than control cells. Dual fluorescence staining with acridine orange and propidium iodide allowed for discrimination between viable, apoptotic, secondary necrotic, and necrotic cells, respectively. Compared with the usual trypan blue method of establishing culture viability, dual staining demonstrated that under stressful conditions a significant proportion of cells that excluded trypan blue were also undergoing cell death through apoptosis. In batch cultures the overexpression of bcl-2 more than doubled the membrane intact (MI) cell productive period (the integral of Ml cell density with respect to culture time) and increased the monoclonal antibody (mAb) production by approximately 40% when compared with the control cell line. The overexpression of bcl-2 protein also significantly extended the cell integrity and viability by the suppression of apoptosis in conditions of hypoxia, hyperoxia, glutamine deprivation, glucose deprivation, and serum limitation. The suppression of apoptosis in anaerobic conditions suggests that bcl-2 exerts its antiapoptotic activity by a mechanism that does not involve an oxidative reactive pathway. In conditions of excess thymidine, which suppressed cell proliferation, Ml cell density and specific mAb productivity were further enhanced by the overexpression of bcl-2, which suggests the possibility of accomplishing a controlled proliferation in immortalized cell lines without invoking cell death. Cell size and intracellular mAb were increased for TB/C3 bcl2 cells compared with TB/C3 pEF control cells when analyzed by flow cytometry.
将TB/C3杂交瘤细胞用pEF-MClneopA或pEF bcl2-MClneopA载体转染,以产生对照细胞系(TB/C3 pEF)和过表达“抗凋亡”人bcl-2蛋白的细胞系(TB/C3 bcl2)。通过流式细胞术分析细胞内bcl-2蛋白水平,能够在无药物选择的情况下近乎在线监测bcl-2表达的稳定性。在非常低的稀释率下进行半连续培养时,有可能维持bcl-2蛋白过表达细胞的自发选择,此时细胞处于营养限制和高毒性代谢物浓度的选择条件下。有趣的是,过表达bcl-2的细胞比对照细胞更快地适应悬浮培养条件。用吖啶橙和碘化丙啶进行双重荧光染色分别可以区分活细胞、凋亡细胞、继发性坏死细胞和坏死细胞。与常用的台盼蓝法确定培养活力相比,双重染色表明在应激条件下,相当一部分排斥台盼蓝的细胞也正在通过凋亡发生细胞死亡。在分批培养中,与对照细胞系相比,bcl-2的过表达使膜完整(MI)细胞生产期(MI细胞密度相对于培养时间的积分)增加了一倍多,并使单克隆抗体(mAb)产量提高了约40%。在缺氧、高氧、谷氨酰胺缺乏、葡萄糖缺乏和血清限制条件下,bcl-2蛋白的过表达还通过抑制凋亡显著延长了细胞完整性和活力。在厌氧条件下对凋亡的抑制表明,bcl-2通过一种不涉及氧化反应途径的机制发挥其抗凋亡活性。在过量胸苷抑制细胞增殖的条件下,bcl-2的过表达进一步提高了MI细胞密度和特异性mAb生产力,这表明在永生化细胞系中实现受控增殖而不引发细胞死亡的可能性。通过流式细胞术分析,与TB/C3 pEF对照细胞相比,TB/C3 bcl2细胞的细胞大小和细胞内mAb增加。